Heart drug developer Kardigan seeks $1.4bn valuation in US IPO

Dollarama beats forecasts; Takeda's psoriasis drug shines; Xiaomi plans new EV

Heart drug developer Kardigan seeks $1.4bn valuation in US IPO
Dollarama beats forecasts; Takeda's psoriasis drug shines; Xiaomi plans new EV